High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
第一作者:
Emi,Sometani
第一单位:
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
作者:
DOI
10.1111/hepr.14111
PMID
39291388
发布时间
2024-09-18
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文